Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F. 2012

C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. crwhite@uab.edu

Myeloperoxidase (MPO)-derived hypochlorous acid induces changes in HDL function via redox modifications at the level of apolipoprotein A-I (apoA-I). As 4F and apoA-I share structural and functional properties, we tested the hypothesis that 4F acts as a reactive substrate for hypochlorous acid (HOCl). 4F reduced the HOCl-mediated oxidation of the fluorescent substrate APF in a concentration-dependent manner (ED(50) ∼ 56 ± 3 μM). This reaction induced changes in the physical properties of 4F. Addition of HOCl to 4F at molar ratios ranging from 1:1 to 3:1 reduced 4F band intensity on SDS-PAGE gels and was accompanied by the formation of a higher molecular weight species. Chromatographic studies showed a reduction in 4F peak area with increasing HOCl and the formation of new products. Mass spectral analyses of collected fractions revealed oxidation of the sole tryptophan (Trp) residue in 4F. 4F was equally susceptible to oxidation in the lipid-free and lipid-bound states. To determine whether Trp oxidation influenced its apoA-I mimetic properties, we monitored effects of HOCl on 4F-mediated lipid binding and ABCA1-dependent cholesterol efflux. Neither property was altered by HOCl. These results suggest that 4F serves as a reactive substrate for HOCl, an antioxidant response that does not influence the lipid binding and cholesterol effluxing capacities of the peptide.

UI MeSH Term Description Entries
D006997 Hypochlorous Acid An oxyacid of chlorine (HClO) containing monovalent chlorine that acts as an oxidizing or reducing agent. Hypochlorite,Hypochlorous Acids
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I

Related Publications

C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
June 2015, Journal of lipid research,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
November 2017, Oncotarget,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
August 2014, Circulation,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
March 2020, American journal of physiology. Regulatory, integrative and comparative physiology,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
February 2019, Investigative ophthalmology & visual science,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
September 2011, Journal of cellular biochemistry,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
September 2014, American journal of physiology. Regulatory, integrative and comparative physiology,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
December 2017, Journal of cellular and molecular medicine,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
January 2020, Frontiers in pharmacology,
C Roger White, and Geeta Datta, and Amanda K W Buck, and Manjula Chaddha, and Gautam Reddy, and Landon Wilson, and Mayakonda N Palgunachari, and Mohammad Abbasi, and G M Anantharamaiah
January 2017, Frontiers in pharmacology,
Copied contents to your clipboard!